Gerber, LLC Monopar Therapeutics Transaction History
Gerber, LLC
- $119 Billion
- Q1 2024
A detailed history of Gerber, LLC transactions in Monopar Therapeutics stock. As of the latest transaction made, Gerber, LLC holds 28,005 shares of MNPR stock, worth $22,964. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,005
Previous 28,005
-0.0%
Holding current value
$22,964
Previous $9.53 Million
100.18%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding MNPR
# of Institutions
16Shares Held
390KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny192KShares$157,7520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.2KShares$37,0360.0% of portfolio
-
Geode Capital Management, LLC Boston, MA41.2KShares$33,7830.0% of portfolio
-
Hrt Financial LP New York, NY32.1KShares$26,3320.0% of portfolio
-
Virtu Financial LLC New York, NY23.8KShares$19,5380.0% of portfolio
About Monopar Therapeutics
- Ticker MNPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,725,800
- Market Cap $10.4M
- Description
- Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...